Valuation: Novartis AG

Market Cap 270B 237B 224B 204B 381B 25,877B 384B 2,682B 1,039B 13,170B 1,012B 990B 42,856B P/E 2026 *
20.2x
P/E 2027 * 17.1x
Enterprise Value 301B 265B 250B 228B 426B 28,908B 429B 2,997B 1,161B 14,713B 1,131B 1,106B 47,876B EV / Sales 2026 *
5.22x
EV / Sales 2027 * 4.84x
Free-Float
91.66%
Yield 2026 *
3.03%
Yield 2027 * 3.17%
1 day+1.27%
1 week+4.10%
Current month-3.49%
1 month-6.64%
3 months-3.61%
6 months+2.45%
Current year+8.54%
1 week 114.86
Extreme 114.86
119.84
1 month 110.3
Extreme 110.3
132.68
Current year 107.68
Extreme 107.68
132.68
1 year 97.05
Extreme 97.05
132.68
3 years 81.1
Extreme 81.1
132.68
5 years 72.84
Extreme 72.84
132.68
10 years 65.09
Extreme 65.09
132.68
Manager TitleAgeSince
Chief Executive Officer 50 31/01/2018
Director of Finance/CFO - 15/03/2026
Compliance Officer 58 13/04/2025
Director TitleAgeSince
Director/Board Member 67 31/12/2014
Director/Board Member 69 31/12/2015
Director/Board Member 61 31/12/2015
Date Insider Type Main position Quantity % Market Cap. Importance
18/05/26 Sell -5,200 0.0003%
04/05/26 Sell 6,800 0.0003%
17/02/26 Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+1.16%+4.10%+21.99%+29.39% 271B
+2.68%+3.87%+58.22%+114.68% 1,026B
+0.56%+1.27%+53.29%+68.65% 649B
+0.02%+0.99%+19.10%+73.58% 468B
+0.06%+0.25%+37.03%+45.71% 352B
-0.24%+2.18%+10.14%+12.26% 256B
-0.01%+6.91%+45.42%+52.15% 220B
-1.11%-0.80%+31.63%+99.95% 188B
+0.30%-7.19%-32.43%-60.56% 170B
+0.82%+3.46%+17.74%-13.09% 161B
Average +0.54%+0.85%+26.21%+42.27% 375.97B
Weighted average by Cap. +1.13%+1.02%+36.73%+64.28%

Financials

2026 *2027 *
Net sales 57.74B 50.79B 47.88B 43.68B 81.69B 5,543B 82.33B 575B 223B 2,821B 217B 212B 9,180B 61.39B 54B 50.91B 46.45B 86.86B 5,893B 87.54B 611B 237B 2,999B 231B 226B 9,760B
Net income 14.2B 12.49B 11.77B 10.74B 20.08B 1,363B 20.24B 141B 54.74B 694B 53.3B 52.14B 2,257B 15.75B 13.86B 13.06B 11.92B 22.29B 1,512B 22.46B 157B 60.74B 770B 59.15B 57.86B 2,504B
Net Debt 31.58B 27.78B 26.18B 23.89B 44.68B 3,031B 45.03B 314B 122B 1,543B 119B 116B 5,020B 27.89B 24.53B 23.12B 21.1B 39.45B 2,677B 39.76B 277B 108B 1,362B 105B 102B 4,433B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
24/09/26 CHF 118.96 +1.16% 3,316,969
23/09/26 CHF 117.60 +0.98% 3,261,410
22/09/26 CHF 116.46 +0.28% 2,904,594
21/09/26 CHF 116.14 +0.90% 2,020,945
18/09/26 CHF 115.10 -0.79% 8,399,187
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
142.54USD
Average target price
152.43USD
Spread / Average Target
+6.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock